Company / Current Liabilities
Phathom Pharmaceuticals, Inc. Current Liabilities History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$132.0M
FY2025
5-year range
$18.9M / $132.0M
FY2021-FY2025
Trend
+54.0%
vs FY2024
Sector context
#83 of 213
Health Care
What the data says
At $132M, Phathom Pharmaceuticals, Inc.'s current liabilities ranks #131 of 213 in the Health Care sector. Current Liabilities has increased for 4 consecutive years, from $19M in FY2021 to $132M in FY2025.
Based on SEC 10-K filings.
$132M in FY2025 with a 5-year CAGR of +18.9%.
Increased from $39M to $132M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +71.4%
- 5-Year CAGR
- +18.9%
- 10-Year CAGR
- -
Sector benchmark
#131 of 213 in Health CareTop 61% of 213This company $132.0M Sector average $1.6B
▼
-91.7% below sector average
Key checks
Key Insights
- Phathom Pharmaceuticals, Inc.'s current liabilities has grown for 4 consecutive years.
- 5-year CAGR of +18.9%, indicating consistent growth.
- In FY2025, current liabilities increased 54.0% year-over-year.
- Ranks #83 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $132.0M | +54.0% |
| FY2024 | $85.7M | +121.1% |
| FY2023 | $38.8M | +47.8% |
| FY2022 | $26.2M | +38.7% |
| FY2021 | $18.9M | -65.9% |
| FY2020 | $55.5M | +1381.4% |
| FY2019 | $3.7M | +71.3% |
| FY2018 | $2.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026